Envision Healthcare Corporation (EVHC): Checking the Operational Data

Envision Healthcare Corporation (NYSE:EVHC) has recently been identified as an interesting stock but more in-depth monitoring is needed for a trade decision. Now trading with a market value of 3.23B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. In light of the many issues surrounding this company, we thought it was a good time to take a close look at the numbers in order to form a realistic perspective on the fundamental picture for this stock.

Envision Healthcare Corporation (NYSE:EVHC) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For EVHC, the company currently has 311.6 million of cash on the books, which is offset by 46.8 million in current liabilities. The trend over time is important to note. In this case, the company’s debt has been falling. The company also has 16.69 billion in total assets, balanced by 9.56 billion in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Envision Healthcare Corporation (EVHC) saw 57.4 million in free cash flow last quarter, representing a quarterly net change in cash of -88.6 million. Perhaps most importantly where cash movements are concerned, the company saw about 98.1 million in net operating cash flow.

Envision Healthcare Corporation (NYSE:EVHC) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 1.88 billion in total revenues. That represents a quarterly year/year change in revenues of 1.59 in sequential terms, the EVHC saw sales decline by 0.35.

But what about the bottom line? After all, that’s what really matters in the end. Envision Healthcare Corporation (EVHC) is intriguing when broken down to its core data. The cost of selling goods last quarter was 1.66 billion, yielding a gross basic income of 221.3 million. For shareholders, given the total diluted outstanding shares of 119.48 million, this means overall earnings per share of -3.84. Note, this compares with a consensus analyst forecast of 0.5 in earnings per share for its next fiscal quarterly report.

Is Envision Healthcare Corporation (NYSE:EVHC) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 2.96 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 8.24. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on Envision Healthcare Corporation.

Previous ArticleNext Article

Related Post

Technical Indicators for Celgene Corporation (CELG... Celgene Corporation (NASDAQ:CELG) fell by -0.76% in Thursday’s trading session from $139.56 to $138.50 and has now fallen 3 consecutive sessions. The ...
Exelon Corporation (EXC) and Hecla Mining Company ... Exelon Corporation (NYSE:EXC) shares are up more than 0.58% this year and recently increased 0.51% or $0.2 to settle at $39.64. Hecla Mining Company (...
Dynavax Technologies Corporation (DVAX) is better ... The shares of Top Ships Inc. have decreased by more than -100.00% this year alone. The shares recently went down by -3.86% or -$0.02 and now trades at...
Abbott Laboratories (ABT): Detailed technical anal... Abbott Laboratories (NYSE:ABT) fell by -0.04% in Monday’s trading session from $54.65 to $54.63 and has now fallen 3 consecutive sessions. The stock p...
The Fundamental Facts on Gilead Sciences (GILD) Gilead Sciences, Inc. (NASDAQ:GILD) is one of the active stocks and its unusual movement is raising eyebrows among traders. Now trading with a market ...